Enzo Challenges Bioequivalence Standard
Enzo Pharmaceutical Holdings Inc. has urged U.S. regulators not to rely on a newly proposed standard for determining whether proposed generic substitutes for Endo's Lidoderm topical pain patch meet the requirements...To view the full article, register now.
Already a subscriber? Click here to view full article